Full Text View
Tabular View
No Study Results Posted
Related Studies
Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy
This study has been completed.
Study NCT01587339   Information provided by GlaxoSmithKline

First Received on April 26, 2012.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
Additional conditions recognized in this trial
Epilepsies, Partial
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
retigabine/ezogabine
lacosamide
zonisamide
pregabalin
eslicarbazepine
Additional drug interventions recognized in this trial
D 23129
More general drug interventions related to this trial
Analgesics
Anticonvulsants
Antioxidants
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services